Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-arginine is the D-enantiomer of the amino acid arginine. Unlike L-arginine, which is a natural substrate for nitric oxide synthase and involved in numerous physiological processes such as cell division, immune function, and vasodilation via nitric oxide production[6][7], D-arginine is not directly utilized in these pathways. It is widely used as an inactive control in studies of the L-arginine/nitric oxide pathway[2][5]. However, research indicates that D-arginine itself may have pharmacological activity; at certain doses it can display central stimulant or depressant effects and has shown anticonvulsant properties in animal models[2][5]. It has also been studied for its potential neuroprotective effects against glucocorticoid-induced neurotoxicity[8] and investigated for roles in metabolic disorders and brain development[3][4]. In supplements and research settings, it may be used to enhance nitric oxide production (though less efficiently than L-form), improve blood flow, support cardiovascular health, or as a nutrient supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on d-arginine.